Company intelligence / Profile preview
Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Suzhou, Jiangsu, Chinapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Phase 1
01
Overview
Suzhou Zanrong Pharmaceutical Technology Co. Ltd., established in 2018 and based in Hong Kong with R&D centers in Shanghai and Suzhou, is a clinical-stage biotech company developing innovative small-molecule oncology drugs. The company focuses on differentiated "best-in-class" and "first-in-class" therapeutics targeting substantial unmet needs in oncology—especially brain metastases from HER2-positive breast cancer. Its lead program ZN-A‑1041 is an oral HER2 inhibitor designed to cross the blood-brain barrier; it has reached Phase I trials and was globally licensed to Roche for further development and commercialization. Another pipeline asset targets ATM for advanced solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Roche – exclusive global licensing agreement for ZN-A‑1041 as of May 2023.
Beyond the preview
Go deeper on Suzhou Zanrong Pharmaceutical Technology Co. Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suzhou Zanrong Pharmaceutical Technology Co. Ltd..